COT Meeting: 29th March 2022

Meeting Agenda

1. Apologies for absence  

2. Draft minutes and reserved minutes of the February meeting TOX/MIN/2022/01  Draft minutes of the extraordinary meeting  on BPA  TOX/MIN/2022/02  

3. Matters arising   

4. Third draft statement on the effects of excess Vitamin A on  maternal health TOX/2022/18 

5. Discussion paper on the potential risk to human health of  Turmeric and curcumin supplements - following a recent  product survey. TOX/2022/19 

6. Evaluation of the potential approaches to mixture risk assessment for future UK REACH assessments TOX/2022/20  

7. First draft statement on the potential risks from cadmium in the  maternal diet TOX/2022/21

8. Updated discussion paper on the bioavailability of nicotine and  other ingredients from the use of oral nicotine pouches and   assessment of risk to users TOX/2022/22  

9. Second draft statement on the risk assessment of cow’s milk in children aged 1 to 5 years, in the context of plant-based drinks   evaluations risk TOX/2022/23  

10. AE JEG Opinion on the Safety of the Extension of Use of E471 (mono- and di-glycerides of fatty acids) for use as a Surface Treatment of Fresh Fruits and Vegetables  (RESERVED) TOX/2022/24 

11. AE JEG Opinion on the safety of the extension of use of polyglycerol polyricinoelate (E476) in edible ices and emulsified sauces –  (RESERVED) TOX/2022/25   

12. Update on the work of other advisory committees TOX/2021/26 - for information  

13. Any other business

Next meeting of the Committee at 10.00am on Tuesday 10th May 2022.  

Matters arising:

• Vitamin D TOX/2022/17 

• JEGs update

Media discussed during the meeting

Please see information on reserved items on the Procedure for holding COT meetings in open session page

TOX/MIN/2022/01

Draft minutes of the 8th February 2022 meeting

TOX/MIN/2022/02  

Draft minutes of the extraordinary meeting on BPA 10th February 2022

TOX/2022/17 

Matters Arising: assessment of EFSA’s vitamin D tolerable upper level (TUL) for 6-12 month-olds

TOX/2022/18 

Third Draft Statement on the effects of excess Vitamin A on maternal health

TOX/2022/19 

Discussion paper on the potential risk to human health of Turmeric and curcumin supplements - following a recent product survey

Annex A TOX/2022/19

Annex A-Discussion paper on the potential risk to human health of turmeric and curcumin supplements - following a recent product survey

Annex B TOX/2022/19

(Reserved)

Cover page Annex B  TOX/2022/19

Cover page-Discussion paper on the potential risk to human health of turmeric and curcumin supplements - following a recent product survey

TOX/2022/20  

Evaluation of the potential approaches to mixture risk assessment for future UK REACH assessments

Annex A TOX/2022/20

This document is not in a fully accessible format, if you require it to be fully accessible, please contact us.  

TOX/2022/21 

First Draft Statement on the potential risks from cadmium in the maternal diet

Annex A TOX/2022/21

Annex A -First Draft Statement on the potential risks from cadmium in the maternal diet

Annex B TOX/2022/21

(Reserved)

TOX/2022/22

Updated discussion paper on the bioavailability of nicotine and other ingredients from the use of oral nicotine pouches and assessment of risk to users

TOX/2022/23  

Second draft statement on the risk assessment of cow’s milk in children aged 1 to 5 years, in the context of plant-based drinks evaluations

Annex A to TOX/2022/23

Annex A - Second draft statement on the risk assessment of cow’s milk in children aged 6 months to 5 years, in the context of plant-based drinks evaluations

TOX/2022/24 

(Reserved)

TOX/2022/25 

(Reserved)

TOX/2021/27

Update on the work of other Scientific Advisory Committees- March 2022

Final minutes of the meeting of the Committee on 29th March 2022

Final minutes of the 29th March 2022 meeting

The final minutes of the meeting of the Committee held on Tuesday 29th March 2022